B Beta Drugs Limited: insider trades · India · SEBI (PIT + SAST) SEBI:beta-drugs-limited IN IN · SEBI (PIT + SAST)
Discover the full directors' dealings record of Beta Drugs Limited, a listed equity based in India. Shares trade on IN IN, under the supervision of SEBI (PIT + SAST). The latest transaction was reported on 13 November 2025 (Sale). Among the most active insiders: Rahul Batra. The full history is free.
Last declaration on 13 November 2025
Declarations 9 total
Executives ● Sale0 SEBI
€3m 185,115 shares @ €16.4048
Equity Shares
SEBI:1958a7891f79861bf1281331128fa0c0e8be53dc · 13 Nov 2025
Executives ● Purchase0 SEBI
029 shares
Equity Shares
SEBI:d0226d65f146d2dd2e4d299d89ebebba53ba3eb2 · 27 Mar 2025
Ideal exit: 22 Dec 2025 (T+270) Executives ● Purchase0 SEBI
01,661 shares
Equity Shares
SEBI:9611c2def99de32659890625920a08ac384ac287 · 27 Mar 2025
Ideal exit: 22 Dec 2025 (T+270) Executives ● Purchase0 SEBI
0317,083 shares
Equity Shares
SEBI:e76b9f5253b08792f7304fb0ae298afb2a7d3d33 · 27 Mar 2025
Ideal exit: 22 Dec 2025 (T+270) Executives ● Purchase0 SEBI
029 shares
Equity Shares
SEBI:85f3cf1b417c549f8c1c61ba82b862bb30a66ae7 · 27 Mar 2025
Ideal exit: 22 Dec 2025 (T+270) Executives ● Purchase0 SEBI
01,982 shares
Equity Shares
SEBI:5a1c1a2d761fe314225d6851c3cd5a7a01c1700e · 27 Mar 2025
Ideal exit: 22 Dec 2025 (T+270) Executives ● Purchase0 SEBI
€18,668 2,400 shares @ €7.7782
Equity Shares
SEBI:a2598f60aaa9edc0f9787e0626d54eecba3e1cbf · 20 Jan 2023
Ideal exit: 17 Oct 2023 (T+270) Executives ● Purchase0 SEBI
€18,668 2,400 shares @ €7.7782
Equity Shares
SEBI:1d4bfa14f33956c69b57dabb1808e7f6f21d1737 · 20 Jan 2023
Ideal exit: 17 Oct 2023 (T+270) Executives ● Purchase0 SEBI
€19,353 2,800 shares @ €6.9119
Equity Shares
SEBI:a9788a49c171a20b8ed3b903cb3915519225b9d8 · 4 Nov 2021
Ideal exit: 1 Aug 2022 (T+270)